November 7, 2022 Arsenal Capital Partners Increases Investment in Global Biosimulation Leader Certara with $449M Stock Purchase
October 19, 2022 Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) Renews Licenses of Certara’s Software for Evaluating Regulatory Submissions
August 5, 2022 Certara Introduces Update of Pinnacle 21™ Enterprise and New Pinnacle 21™ Data Exchange Module
July 28, 2022 Certara Announces Collaboration with Leading Cancer Center to Advance CAR T-cell Therapies